Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients

Journal of Clinical Pharmacology

Volumn 39, Issue 11, 1999, Pages 1136-1142

  Alshowaier, I A ^a   El Yazigi, A ^a   Ezzat, A ^a   El Warith, A A ^a   Nicholls, P J ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE INHIBITOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CHIRALITY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; ENANTIOMER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN;

ADULT; AGED; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; STEREOISOMERISM; TIME FACTORS;

EID: 0033327692     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer
2. Multicentre cross-over study of aminoglutethimide and trilostane in advanced postmenopausal breast cancer
3. Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma
4. Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone-acetate in therapy for advanced breast carcinoma
5. Treatment of advanced breast cancer with aminoglutethimide: A 14 year experience
6. Medical adrenalectomy with aminoglutethimide in the management of advanced breast cancer
7. Estrogen receptors and the response of metastatic breast cancer to amino-glutethimide or tamoxifen
8. Second-line hormonal therapy for advanced prostate cancer: A shifting paradigm
9. Effects of aminoglutethimide, alone and in combination with surgical castration, on pancreatic carcinogenesis in rats and hamsters
10. Liquid chromatographic separation and measurement of optical isomers of aminoglutethimide and its acetyl metabolite in plasma, saliva, and urine
11. 14C-aminoglutethimide
12. The effect of acetylator phenotype on the disposition aminoglutethimide
13. Single-dose and steady-state pharmacokinetics of aminoglutethimide
14. 14C-aminoglutethimide in the mouse
15. Characterization of aminoglutethimide plasma protein binding in man
16. Aminoglutethimide: Absorption physiological disposition and pharmacokinetics
17. The partial fate of aminoglutethimide in man
18. Aminoglutethimide: Analytical profile of drug substances